S
Subhash Chand
Researcher at University of Nebraska Medical Center
Publications - 17
Citations - 412
Subhash Chand is an academic researcher from University of Nebraska Medical Center. The author has contributed to research in topics: Myoglobin & Thioanisole. The author has an hindex of 9, co-authored 17 publications receiving 220 citations. Previous affiliations of Subhash Chand include The Catholic University of America & University of Texas at Arlington.
Papers
More filters
Journal ArticleDOI
Mesenchymal Stem Cell-Derived Extracellular Vesicles: Challenges in Clinical Applications
TL;DR: Light is shed on the challenges faced in MSC-EV research in translating successful preclinical studies to clinical platforms and several critical issues such as production methods, quantification and characterization, pharmacokinetics, targeting and transfer to the target sites, and safety profile assessments need to be resolved.
Journal ArticleDOI
Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System
TL;DR: The challenges in potential EV-based therapeutic delivery are outlined, which can be exploited to potentially devise novel therapeutic delivery system for central nervous system (CNS) drug targeting.
Journal ArticleDOI
COVID-19 Vaccines Currently under Preclinical and Clinical Studies, and Associated Antiviral Immune Response
TL;DR: The major vaccine candidates based on the specific vaccine platform utilized to develop them were reviewed and the immune responses generated by these candidates in humans and preclinical models to determine vaccine safety, immunogenicity, and efficacy were discussed.
Journal ArticleDOI
Role of microRNAs in the pathophysiology of addiction
Austin Gowen,Katherine E. Odegaard,J.L. Hernández,Subhash Chand,Sneh Koul,Gurudutt Pendyala,Sowmya V. Yelamanchili +6 more
TL;DR: The goal in this systematic review is to provide a detailed account of recent research involving the role of miRNAs in addiction.
Journal ArticleDOI
Downregulation of an Evolutionary Young miR-1290 in an iPSC-Derived Neural Stem Cell Model of Autism Spectrum Disorder
Dalia Moore,Brittney M. Meays,Lepakshe S. V. Madduri,Farah Shahjin,Subhash Chand,Meng Niu,Abrar Albahrani,Chittibabu Guda,Gurudutt Pendyala,Howard S. Fox,Sowmya V. Yelamanchili +10 more
TL;DR: It is shown that miR-1290 is significantly downregulated during neuronal differentiation in reprogrammed induced pluripotent stem cell- (iPSC-) derived neurons obtained from idiopathic autism spectrum disorder (ASD) patients and regulation could play a critical role during neurons differentiation in early brain development.